We evaluated our hypotheses that vaccine exposure before infection with SARS-CoV-2 in patients with cancer would be associated with overall survival and vaccine exposure would differ by patient ...

Uncovering Surgical Dynamics and Trends in Early Breast Cancer Stage at Diagnosis: Key Insights From a Two-Decade Argentine Database Analysis A minimum of three or four clips were inserted into the ...

Racial/Ethnic Disparities in Oncology Clinical Trial Participation: Investigator Attitudes, Needs, and Motivation to Improve As team-based care in oncology has become a predominant care delivery model ...

The German CLL Study Group conducted a randomized, double-blind, placebo-controlled phase III trial with 363 patients with asymptomatic, treatment-naïve Binet stage A CLL at increased risk of ...

Clip and Blue—An Easy and Cost-Effective Prechemotherapy Localization Technique in Patients With Breast Cancer Planned for Breast Conservation Uncovering real-world data holds immense potential to ...

In conclusion, the legacy of nuclear testing in the Pacific Islands has left profound health, environmental, and cultural impacts on the Indigenous communities. The immediate and long-term effects of ...

The World Cancer Congress 2024 (WCC 2024), 1 organized by the Union for International Cancer Control (UICC), is an important event in advancing the global fight against cancer. This year's conference, ...

A 64-year-old engineer was diagnosed with a cT2cN0M0, Gleason score 8, adenocarcinoma of the prostate. His prostate-specific antigen level was 15 ng/mL. The case was discussed at the hospital tumor ...

Factors Associated With Default of Treatment and Follow-Up Among Patients With Cancer: A Cross-Sectional Study From a Lower-Middle-Income Country This study reports on the current status of Radiation ...

Impact of Cancer Across the Intergenerational Family: A Multidimensional Perspective From African Countries The following represents disclosure information provided by authors of this manuscript. All ...

Pancreatic adenocarcinoma (PDAC) unfortunately remains a highly fatal disease with a 5-year survival rate of only 11%. If surgical resection is not possible, systemic chemotherapy represents the ...

Patients with stage III to IV or recurrent, radiographically apparent EC and no previous chemotherapy or disease progression ≥6 months after neo/adjuvant platinum-based chemotherapy were randomly ...